Patton Fund Management’s Charles River Laboratories CRL Stock Holding History

Patton Fund Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,362	Closed	-$235K	–	177
2026 Q1	$235K	Buy	1,362 +97	+8%	+$18K	0.04%	362
2025 Q4	$252K	Sell	1,265 -655	-34%	-$119K	0.03%	100
2025 Q3	$300K	Hold	1,920	–	–	0.05%	113
2025 Q2	$291K	Buy	+1,920	New	+$256K	0.06%	87
2021 Q4	–	Sell	-4,652	Closed	-$1.92M	–	95
2021 Q3	$1.92M	Buy	+4,652	New	+$1.93M	0.73%	39

Other funds holding CRL

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

IHL

Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return

CPCPP

Canada Post Corporation Pension Plan Toronto, Canada $2.87B AUM 37.96% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

CCMINC

Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $826M AUM 32.06% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Patton Fund Management's CRL Position: Q2 2026 in Review

Patton Fund Management sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 1,362 shares — an estimated $235K sold.

Patton Fund Management first reported a position in CRL in Q3 2021 and held it in 5 quarters. The position peaked at $1.92M in Q3 2021. 77 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Patton Fund Management reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
Patton Fund Management sold 1,362 Charles River Laboratories shares in Q2 2026, an estimated $235K.
Patton Fund Management first reported a position in Charles River Laboratories in Q3 2021 and held it in 5 quarters.
Patton Fund Management's Charles River Laboratories position peaked at $1.92M in Q3 2021.
77 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Patton Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.